Avid Bioservices Inc (CDMO)

[porkchop11]

Comment on fool article...

Report this Comment On September 23, 2013, at 7:30 PM, BBTERPS wrote:
Just for the record PPHM did salvage enough data from the trial botched by the third party that handled the double blind trial. The third party was an FDA approved vendor.

That was a phase 2 trial for NSCLC, after establishing one arm of the trial (a 3 MG dose of Bavituximab) was untainted they were approved for a phase 3 trial with 600 patients and a early review possible.

Without the screw up they would have realized a 109% improvement over SOC. Even after they had tp combine there 1mg Bavi arm of the trial and SOC, PPHM still had a 60% improvement. This out performs any historical data for this difficult unmet need.